AlisonHall(Hall)SkaletMD

Ophthalmology • Portland, OR

Retinal Disease, Ocular Oncology

Associate Professor, Ophthalmology, Oregon Health and Science University School of Medicine

Join to view full profile

Dr. Skalet is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Skalet's full profile

Already have an account?

Office
3375 SW Terwilliger Blvd
Portland, OR 97239
Phone+1 503-494-7881

Fax+1 503-494-3339

Education & Training

Oregon Health & Science UniversityFellowship, Ocular Oncology/Ophthalmic Pathology, 2011 - 2012
University of California (San Francisco)Residency, Ophthalmology, 2008 - 2011
Childrens Hospital of PhiladelphiaInternship, Transitional Year, 2006 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2006

Certifications & Licensure

CA State Medical License 2009 - 2025
OR State Medical License 2011 - 2025
PA State Medical License 2006 - 2007
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Vascular Response to Brachytherapy Using Functional OCT Start of enrollment: 2013 Oct 01
Completed

Publications & Presentations

PubMed

Concurrent Unilateral Retinoblastoma and Giant Suprasellar Pilomyxoid Astrocytoma.
Maryam N Shahin, Adeline L Fecker, Michael Gale, Ishan Ahluwalia, Nathan R Selden
Pediatric Blood & Cancer. 2024-11-24
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case-control...
Christiaan M de Bloeme, Robin W Jansen, Liesbeth Cardoen, Sophia Göricke, Sabien van Elst
Scientific Reports. 2024-10-23
2 citations
15-Gene Expression Profile andas Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).
J William Harbour, Zelia M Correa, Amy C Schefler, Prithvi Mruthyunjaya, Miguel A Materin
Journal of Clinical Oncology. 2024-10-01

Journal Articles

Risk Factors and Disease Course for Blood-Brain Barrier Disruption–Associated Maculopathy
Joseph M Simonett, Alison H Skalet, Brandon J Lujan, JAMA Ophthalmology

Press Mentions

Genetic Testing Recommended for Children Considered at Risk for Most Common Eye CancerOctober 18th, 2017

Professional Memberships

International Society of Ocular Oncology
Member
American Association of Ophthalmic Oncologists and Pathologists
Member